News and Events


Dr. Natalia Tretyakova has been awarded a grant for $1.7 million from the National Institutes of Health for the project "Smoking-Induced Epigenetic Changes in the Lung: Role of DNA Demethylation," on which she is the principal investigator. 

Dr. Carrie Haskell-Luevano received a $125,000 Winston and Maxine Wallin Neuroscience Discovery Fund grant for her project, "Discovery of Opioid Receptor Endogenous Allosteric Modulators For the Treatment of Pain and Addiction." Dr. Philip Portoghese is a co-investigator on the project.

Dr. Gunda Georg is the Principle Investigator of a $8.3M National Institutes of Health U54 Center Grant titled Contraceptive Discovery, Development, and Behavioral Research Center (2017-2021). In addition to Drs.

Dr. Stephen Hecht was named one of the 2017 Dean's Distinguished Research Lectureship Honorees, which recognizes the best research faculty in the basic and clinical sciences. To be considered, honorees must have the first or last author credits on a publication that has been cited at least 1,000 times by others. Dr. Hecht will give a presentation on his research at the award ceremony on October 26th. The announcement is here.

Drs. Gunda Georg and Rebecca Cuellar of the ITDD were featured in the Star Tribune story, "Male Contraception Gaining Sex Appeal, Gustavus Survey Finds." They discuss their research and development of H2-Gamendazole, a molecule which causes reversible infertility. You can read the full article here.

Congratulations to Dr. Peter Dosa of the ITDD, who received an Investigator-Initiated Research Award of $2,278,764. The project will be funded by the Department of Defense's Congressionally Directed Medical Research Programs.

The National Institute for Pharmaceutical Technology and Education (NIPTE), which boasts Medicinal Chemistry's own Dr. Vadim Gurvich as executive director, was recently awarded $35 million dollars in funding from the Food and Drug Administration, to be allocated over a 5-year period. The grant will support a multitude of different projects in the pharmaceutical field from improvements in manufacturing and technology to research and education.

Dr. Michael Walters of the Institute for Therapeutics Discovery and Development has been awarded one of six recent grants from the Minnesota Partnership for Biotechnology and Medical Genomics. Dr. Walters project "Precision Medicine of Aromatase Inhibitors in Post-Menopausal Women with ER+ Breast Cancer," seeks to use DNA sequencing to study the unique responses that different individuals have to aromatase inhibitors, which are often a first treatment step to the most common type of breast cancer. By studying DNA differences, Dr.

Dr. Gunda Georg was recently interviewed for the CNN documentary series This is Sex with Lisa Ling, which explores how sex is perceived, discussed, and stigmatized in the U.S. She is shown working in her lab and discussing her work into the development of a male contraceptive pill.

Dr. Courtney Aldrich was recently quoted in an article by Chemical & Engineering News discussing recent breakthroughs in identifying enzymes that characterize the psilocybin compound found in "magic mushrooms." As Dr.